Hitachi High-Tech has opened a demonstration laboratory in Mumbai for analytical systems, its second such facility in India. The lab, the Advanced-Technology Innovation Center Mumbai, opened on 1 October in the MIDC area of Thane.
It focuses on analytical systems — spectrophotometers, liquid chromatographs, thermal analyzers and titrators — for biopharmaceuticals, environmental, materials and other chemical and industrial fields. Hitachi High-Tech India, the group’s local subsidiary, runs the facility. It offers demonstrations, sample evaluation and technical consultation.
Hitachi High-Tech’s two-site India strategy
The Mumbai lab pairs with a Bengaluru site that Hitachi High-Tech opened in 2025. That one focuses on semiconductors and houses electron microscopes, including the FE-SEM SU8600.
Together the two sites give the company a footprint covering semiconductors and electronics on one side, and chemicals and industrial fields on the other. Hitachi frames the move as strengthening its “digitalized assets” for HMAX Industry, Hitachi Group’s next-generation industrial solutions suite built around what it calls physical AI.
Why India, why now
India’s analytical-instrument market is growing quickly, driven by its pharmaceutical and biopharmaceutical manufacturing base. Estimates vary widely. One puts the India analytical instrument market at about US$1.9 billion in 2026, reaching US$3.0 billion by 2034. Another estimates US$4.18 billion in 2025 rising to about US$11.87 billion by 2035.
The biopharmaceutical slice is expanding faster. India’s biopharmaceutical process analytical technology market was valued at about US$42.7 million in 2024. It is projected to reach US$107.4 million by 2029, a 20.2% compound annual rate. The number of Indian biotech startups rose from around 50 in 2014 to nearly 9,000 by 2025.
The competitive picture
Hitachi High-Tech is not first to build a demo lab in India. Agilent opened its first India Solution Center at Manesar in May 2025, a 12,500-square-foot facility for method development, proof-of-concept work and training. Shimadzu has also expanded its India partnerships.
So the Mumbai lab is less a first than a catch-up move. Global instrument makers are racing to put application support close to Indian customers.
A note on timing
Hitachi High-Tech announced the Mumbai lab on 16 September 2026, ahead of its 1 October opening. The version distributed to journalists through PR Newswire carried a 5 October dateline. Readers should treat the announcement as a re-issued one, not a fresh development.
What to watch
Whether Hitachi adds a third site, and which field it targets. Whether the labs translate into disclosed India revenue or installations — the company does not break these out. And whether the HMAX Industry framing reaches the analytical lab business, or stays a group-level message.
India’s instrument market is growing because its pharma and semiconductor industries are. The labs are where the vendors compete for that growth.
Editor’s Note
Sources: Hitachi High-Tech’s release of 16 September 2026, distributed through PR Newswire on 5 October 2026; Hitachi High-Tech India’s site announcements; market research on India’s analytical-instrument and process-analytical-technology markets; and reporting on Agilent‘s 2025 India Solution Center. Hitachi’s facility and product details are its own. Market-size estimates vary by methodology and are cited as ranges. TechRecast has not independently verified the lab’s capabilities.